Viral Vector and Plasmid DNA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

List of Figures, Tables and Charts Available in Viral Vector and Plasmid DNA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

List of Tables
Table 1. Viral Vector and Plasmid DNA Market Trends
Table 2. Viral Vector and Plasmid DNA Market Drivers & Opportunity
Table 3. Viral Vector and Plasmid DNA Market Challenges
Table 4. Viral Vector and Plasmid DNA Market Restraints
Table 5. Global Viral Vector and Plasmid DNA Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Viral Vector and Plasmid DNA Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Viral Vector and Plasmid DNA Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Viral Vector and Plasmid DNA Product Type
Table 9. Key Companies Time to Begin Mass Production of Viral Vector and Plasmid DNA
Table 10. Global Viral Vector and Plasmid DNA Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Viral Vector and Plasmid DNA Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Viral Vector and Plasmid DNA Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Viral Vector and Plasmid DNA Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Viral Vector and Plasmid DNA Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Viral Vector and Plasmid DNA Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Viral Vector and Plasmid DNA Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Viral Vector and Plasmid DNA Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Viral Vector and Plasmid DNA Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Viral Vector and Plasmid DNA Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Viral Vector and Plasmid DNA Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Viral Vector and Plasmid DNA Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Viral Vector and Plasmid DNA Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Viral Vector and Plasmid DNA Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Viral Vector and Plasmid DNA Sales Value by Region (2019-2024) & (%)
Table 27. Global Viral Vector and Plasmid DNA Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Viral Vector and Plasmid DNA Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Viral Vector and Plasmid DNA Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Viral Vector and Plasmid DNA Sales Value, (2025-2030) & (US$ Million)
Table 31. Brammer Bio Basic Information List
Table 32. Brammer Bio Description and Business Overview
Table 33. Brammer Bio Viral Vector and Plasmid DNA Products, Services and Solutions
Table 34. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Brammer Bio (2019-2024)
Table 35. Brammer Bio Recent Developments
Table 36. Oxford BioMedica Basic Information List
Table 37. Oxford BioMedica Description and Business Overview
Table 38. Oxford BioMedica Viral Vector and Plasmid DNA Products, Services and Solutions
Table 39. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Oxford BioMedica (2019-2024)
Table 40. Oxford BioMedica Recent Developments
Table 41. Cobra Biologics Basic Information List
Table 42. Cobra Biologics Description and Business Overview
Table 43. Cobra Biologics Viral Vector and Plasmid DNA Products, Services and Solutions
Table 44. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Cobra Biologics (2019-2024)
Table 45. Cobra Biologics Recent Developments
Table 46. FinVector Basic Information List
Table 47. FinVector Description and Business Overview
Table 48. FinVector Viral Vector and Plasmid DNA Products, Services and Solutions
Table 49. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of FinVector (2019-2024)
Table 50. FinVector Recent Developments
Table 51. Lonza Basic Information List
Table 52. Lonza Description and Business Overview
Table 53. Lonza Viral Vector and Plasmid DNA Products, Services and Solutions
Table 54. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Lonza (2019-2024)
Table 55. Lonza Recent Developments
Table 56. BioReliance Basic Information List
Table 57. BioReliance Description and Business Overview
Table 58. BioReliance Viral Vector and Plasmid DNA Products, Services and Solutions
Table 59. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of BioReliance (2019-2024)
Table 60. BioReliance Recent Developments
Table 61. MolMed Basic Information List
Table 62. MolMed Description and Business Overview
Table 63. MolMed Viral Vector and Plasmid DNA Products, Services and Solutions
Table 64. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of MolMed (2019-2024)
Table 65. MolMed Recent Developments
Table 66. FUJIFILM Diosynth Biotechnologies Basic Information List
Table 67. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 68. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Products, Services and Solutions
Table 69. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of FUJIFILM Diosynth Biotechnologies (2019-2024)
Table 70. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 71. UniQure Basic Information List
Table 72. UniQure Description and Business Overview
Table 73. UniQure Viral Vector and Plasmid DNA Products, Services and Solutions
Table 74. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of UniQure (2019-2024)
Table 75. UniQure Recent Developments
Table 76. Aldevron Basic Information List
Table 77. Aldevron Description and Business Overview
Table 78. Aldevron Viral Vector and Plasmid DNA Products, Services and Solutions
Table 79. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Aldevron (2019-2024)
Table 80. Aldevron Recent Developments
Table 81. Richter-Helm Basic Information List
Table 82. Richter-Helm Description and Business Overview
Table 83. Richter-Helm Viral Vector and Plasmid DNA Products, Services and Solutions
Table 84. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Richter-Helm (2019-2024)
Table 85. Richter-Helm Recent Developments
Table 86. Eurogentec Basic Information List
Table 87. Eurogentec Description and Business Overview
Table 88. Eurogentec Viral Vector and Plasmid DNA Products, Services and Solutions
Table 89. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Eurogentec (2019-2024)
Table 90. Eurogentec Recent Developments
Table 91. OBiO Technology Basic Information List
Table 92. OBiO Technology Description and Business Overview
Table 93. OBiO Technology Viral Vector and Plasmid DNA Products, Services and Solutions
Table 94. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of OBiO Technology (2019-2024)
Table 95. OBiO Technology Recent Developments
Table 96. Yposkesi Basic Information List
Table 97. Yposkesi Description and Business Overview
Table 98. Yposkesi Viral Vector and Plasmid DNA Products, Services and Solutions
Table 99. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Yposkesi (2019-2024)
Table 100. Yposkesi Recent Developments
Table 101. Cell and Gene Therapy Catapult Basic Information List
Table 102. Cell and Gene Therapy Catapult Description and Business Overview
Table 103. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Products, Services and Solutions
Table 104. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Cell and Gene Therapy Catapult (2019-2024)
Table 105. Cell and Gene Therapy Catapult Recent Developments
Table 106. MassBiologics Basic Information List
Table 107. MassBiologics Description and Business Overview
Table 108. MassBiologics Viral Vector and Plasmid DNA Products, Services and Solutions
Table 109. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of MassBiologics (2019-2024)
Table 110. MassBiologics Recent Developments
Table 111. Biovian Basic Information List
Table 112. Biovian Description and Business Overview
Table 113. Biovian Viral Vector and Plasmid DNA Products, Services and Solutions
Table 114. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Biovian (2019-2024)
Table 115. Biovian Recent Developments
Table 116. VGXI Basic Information List
Table 117. VGXI Description and Business Overview
Table 118. VGXI Viral Vector and Plasmid DNA Products, Services and Solutions
Table 119. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of VGXI (2019-2024)
Table 120. VGXI Recent Developments
Table 121. Gene Synthesis Basic Information List
Table 122. Gene Synthesis Description and Business Overview
Table 123. Gene Synthesis Viral Vector and Plasmid DNA Products, Services and Solutions
Table 124. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Gene Synthesis (2019-2024)
Table 125. Gene Synthesis Recent Developments
Table 126. PlasmidFactory Basic Information List
Table 127. PlasmidFactory Description and Business Overview
Table 128. PlasmidFactory Viral Vector and Plasmid DNA Products, Services and Solutions
Table 129. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of PlasmidFactory (2019-2024)
Table 130. PlasmidFactory Recent Developments
Table 131. Jikai Gene Basic Information List
Table 132. Jikai Gene Description and Business Overview
Table 133. Jikai Gene Viral Vector and Plasmid DNA Products, Services and Solutions
Table 134. Revenue (US$ Million) in Viral Vector and Plasmid DNA Business of Jikai Gene (2019-2024)
Table 135. Jikai Gene Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Viral Vector and Plasmid DNA Downstream Customers
Table 139. Viral Vector and Plasmid DNA Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Viral Vector and Plasmid DNA Product Picture
Figure 2. Global Viral Vector and Plasmid DNA Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Viral Vector and Plasmid DNA Sales Value (2019-2030) & (US$ Million)
Figure 4. Viral Vector and Plasmid DNA Report Years Considered
Figure 5. Global Viral Vector and Plasmid DNA Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Vector and Plasmid DNA Revenue in 2023
Figure 7. Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Plasmid DNA Picture
Figure 9. Viral Vector Picture
Figure 10. Global Viral Vector and Plasmid DNA Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Viral Vector and Plasmid DNA Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Cancer
Figure 13. Product Picture of Virus Infection
Figure 14. Product Picture of Hereditary Disease
Figure 15. Global Viral Vector and Plasmid DNA Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Viral Vector and Plasmid DNA Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Viral Vector and Plasmid DNA Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Viral Vector and Plasmid DNA Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Viral Vector and Plasmid DNA Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Viral Vector and Plasmid DNA Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Viral Vector and Plasmid DNA Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Viral Vector and Plasmid DNA Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Viral Vector and Plasmid DNA Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Viral Vector and Plasmid DNA Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Viral Vector and Plasmid DNA Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Viral Vector and Plasmid DNA Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Viral Vector and Plasmid DNA Sales Value (%), (2019-2030)
Figure 28. United States Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 34. China Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 36. China Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 46. India Viral Vector and Plasmid DNA Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Viral Vector and Plasmid DNA Sales Value by Type (%), 2023 VS 2030
Figure 48. India Viral Vector and Plasmid DNA Sales Value by Application (%), 2023 VS 2030
Figure 49. Viral Vector and Plasmid DNA Industrial Chain
Figure 50. Viral Vector and Plasmid DNA Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation